BD 671910 - PowerLoc Safety Infusion Set with Y-Injection Site, 19G x 1", 20/PK (Continental US Only)

BD 671910 - PowerLoc Safety Infusion Set with Y-Injection Site, 19G x 1", 20/PK (Continental US Only)

The BD 671910 PowerLoc Safety Infusion Set is a sterile, single-use port-access device designed for accessing compatible surgically implanted vascular ports. The set features a 19-gauge non-coring needle with a 1-inch length, an integrated Y-injection site, and approximately 8-inch tubing for flexible connection during infusion therapy and vascular-access procedures.

The PowerLoc system is designed to support administration of compatible medications and fluids, blood specimen collection, implanted port flushing, and power injection through appropriately rated vascular access systems. The 19-gauge configuration provides a larger fluid pathway suitable for applications requiring higher flow capability.

The 1-inch needle length accommodates implanted ports positioned at a moderate depth beneath the skin. Correct needle-length selection helps support complete septum access, stable positioning, effective dressing application, and appropriate access-site management.

The integrated Y-injection site provides an additional access point within the tubing for compatible intermittent medication administration, flushing, or connection of another approved fluid pathway. The set has an approximate priming volume of 0.4 mL and approximately 8-inch tubing.

An integrated safety mechanism is designed to help reduce accidental needlestick exposure during port deaccessing. The safety design helps protect the needle point after withdrawal and supports safer handling before final sharps disposal.

The PowerLoc platform combines power-injection capability with a compact, winged port-access design intended to support site visibility, dressing placement, stabilization, and efficient clinical workflow. BD 671910 is supplied 20 sets per shelfpack.

Key Benefits

• 19-gauge non-coring needle supports access to compatible surgically implanted vascular ports.
• One-inch needle length accommodates ports positioned at a moderate depth beneath the skin.
• Larger 19-gauge fluid pathway supports applications requiring higher flow capability.
• Power-injectable design supports compatible contrast-enhanced diagnostic imaging procedures.
• Maximum flow rate up to 5 mL per second when the complete vascular-access system is appropriately rated.
• Integrated Y-injection site provides secondary access for compatible medication, flushing, or fluid administration.
• Approximately 8-inch tubing provides practical working length for port-access procedures.
• Approximate 0.4 mL priming volume supports fluid-management planning.
• Non-coring needle design helps minimize unnecessary trauma to compatible implanted port septa during appropriate use.
• Integrated safety mechanism helps protect the needle following port deaccessing.
• Winged hub supports controlled insertion, stabilization, and removal.
• Compact design supports dressing application and access-site management.
• Suitable for compatible infusion therapy, blood sampling, port maintenance, and power-injection workflows.
• Y-site configuration supports flexible clinical connection options when secondary access is required.
• 20-per-shelfpack packaging supports clinical inventory management and routine departmental stocking.

Compatibility and Applications

The BD 671910 PowerLoc Safety Infusion Set is intended for use with compatible surgically implanted vascular access ports designed to accept non-coring port-access needles.

Potential clinical applications include chemotherapy administration, antibiotic therapy, hydration, parenteral nutrition, blood product administration, long-term infusion therapy, blood specimen collection, implanted port flushing, and compatible contrast-media injection during diagnostic imaging procedures.

The 19-gauge configuration may be selected when higher flow capability is required and the implanted port, prescribed therapy, and complete fluid pathway are compatible with a larger-gauge access needle. Selection should consider medication or fluid viscosity, required flow rate, infusion equipment, implanted port specifications, power-injection requirements, and professional clinical judgment.

The 1-inch needle length may be appropriate when a 0.75-inch needle does not provide sufficient depth but a 1.5-inch configuration would provide unnecessary additional length. Patient anatomy, tissue depth, and port position should be assessed before needle selection.

The integrated Y-injection site provides a secondary access point within the tubing. It may support compatible intermittent medication administration, flushing, or connection of another approved fluid pathway when permitted by the prescribed therapy and institutional protocol.

For power injection, the implanted port, PowerLoc needle, tubing, connectors, Y-injection site, extension components, and every other device within the complete fluid pathway must be appropriately rated for the intended procedure. The lowest-rated component determines the maximum allowable pressure and flow rate.

Compatibility should be confirmed with the exact implanted port model, septum design, tissue depth, prescribed therapy, infusion pump, power injector, connector system, dressing materials, and institutional vascular-access procedures.

Usage Guidelines

The BD 671910 should be used only by healthcare professionals trained and authorized to access surgically implanted vascular ports. Current manufacturer instructions, aseptic technique, institutional procedures, and the implanted port manufacturer's directions should be followed throughout the procedure.

• Confirm the patient's identity, prescribed therapy, implanted port type, and power-injection status when applicable.
• Assess the location and depth of the implanted port before selecting the 1-inch needle.
• Verify that the 19-gauge configuration is appropriate for the intended infusion or imaging procedure.
• Confirm that a Y-injection site is suitable for the planned clinical workflow.
• Inspect the sterile package for damage, punctures, moisture, contamination, or compromised integrity.
• Prepare the implanted port site according to institutional skin-antisepsis and sterile-access procedures.
• Prime the primary tubing and any intended secondary fluid pathway with an approved solution.
• Remove air completely from the fluid pathway before accessing the implanted port.
• Stabilize the implanted port and insert the non-coring needle perpendicular to the septum using an approved technique.
• Advance the needle carefully until appropriate access to the port reservoir is achieved.
• Verify correct needle placement according to institutional policy, including aspiration for blood return when clinically appropriate.
• Flush the implanted port according to current manufacturer instructions and facility protocol.
• Position and secure the tubing to minimize pulling, twisting, pressure, and dressing disruption.
• Apply an appropriate sterile dressing while maintaining access-site visibility.
• Disinfect the Y-injection site before every access according to institutional infection-prevention procedures.
• Maintain aseptic technique whenever connecting to or manipulating the Y-injection site.
• Monitor the access site for pain, swelling, redness, leakage, displacement, or other abnormalities.
• Confirm power-injection eligibility before connecting the system to a power injector.
• Do not exceed 5 mL per second or the lower operating limit of any component within the complete vascular-access system.
• After therapy, flush and lock the implanted port according to the prescribed protocol.
• Stabilize the port while withdrawing the needle and activating the safety mechanism.
• Confirm that the needle safety feature has fully engaged before further handling.
• Dispose of the used device immediately in an approved sharps container.

Stop the procedure and assess the vascular-access system if unexpected resistance occurs during flushing, expected blood return cannot be obtained, the patient experiences unusual discomfort, or swelling, leakage, displacement, or another abnormality develops at the implanted port site.

Certifications and Safety Standards

The BD 671910 PowerLoc Safety Infusion Set is intended for professional medical use within established vascular-access, infusion-therapy, diagnostic imaging, infection-prevention, and occupational safety programs.

The product should be incorporated into facility procedures addressing implanted port assessment, hand hygiene, sterile preparation, skin antisepsis, port access, infusion administration, Y-site management, dressing care, power injection, deaccessing, and sharps disposal.

The integrated safety mechanism is designed to help reduce the risk of accidental needle exposure during removal from an implanted vascular port. Correct activation should be confirmed before the used device is transported or discarded.

The safety feature supports needlestick-prevention practices but does not replace appropriate clinician training, personal protective equipment, safe sharps handling, exposure-control procedures, or immediate disposal in an approved sharps container.

The non-coring needle should be selected according to patient anatomy, implanted port depth, prescribed therapy, required flow characteristics, and current manufacturer instructions.

Healthcare organizations should review current manufacturer documentation for applicable FDA status, UDI information, sterilization method, material composition, natural rubber latex information, DEHP information, shelf life, maximum pressure, flow-rate specifications, warnings, precautions, contraindications, and other product-specific regulatory requirements.

Comparison with Competitors

Compared with conventional implanted port needles without integrated safety technology, the BD PowerLoc system incorporates a needle-protection mechanism designed to help reduce accidental sharps exposure during deaccessing and disposal.

Compared with PowerLoc configurations without a Y-injection site, BD 671910 provides an integrated secondary access point within the tubing. This may support compatible intermittent medication administration, flushing, or an additional approved fluid connection without disconnecting the primary pathway.

Compared with non-power-injectable port-access devices, the PowerLoc platform supports compatible power-injection procedures when used with an appropriately rated implanted port and complete vascular-access system.

Compared with 20-gauge and 22-gauge PowerLoc configurations, the 19-gauge needle provides a larger fluid pathway and may be selected when higher flow capability is clinically required. Gauge selection should always consider the implanted port specifications, prescribed procedure, fluid characteristics, and patient needs.

Compared with a 0.75-inch access needle, the 1-inch configuration accommodates ports positioned at a greater tissue depth. Compared with a 1.5-inch needle, it may provide a lower access profile when additional length is unnecessary.

Alternative safety infusion sets may vary in gauge, needle length, power-injection capability, Y-site configuration, tubing length, priming volume, safety mechanism, hub design, and packaging quantity. BD 671910 combines a 19-gauge, 1-inch non-coring needle with a Y-injection site, approximately 8-inch tubing, 0.4 mL priming volume, integrated safety technology, and power-injection capability up to 5 mL per second.

Typical User Profile and Application Scenarios

The BD 671910 PowerLoc Safety Infusion Set is intended for trained healthcare professionals responsible for accessing and managing implanted vascular ports. Typical users include infusion nurses, oncology nurses, radiology nurses, vascular-access specialists, physicians, advanced practice clinicians, and other qualified healthcare personnel.

Common use environments include hospitals, oncology centers, outpatient infusion clinics, diagnostic imaging departments, ambulatory treatment centers, emergency departments, specialty practices, and other healthcare facilities where implanted vascular ports are routinely accessed.

The product may be selected for patients whose implanted port requires a 1-inch access needle and whose prescribed treatment or diagnostic procedure is compatible with a 19-gauge device.

Typical application scenarios include chemotherapy administration, antibiotic infusion, hydration, parenteral nutrition, blood product administration, blood specimen collection, routine implanted port maintenance, and compatible power-injection procedures during diagnostic imaging.

The integrated Y-injection site is particularly useful in workflows requiring secondary access for compatible intermittent medication administration, flushing, or connection of another approved fluid pathway.

Best Practices for Use and Maintenance

The BD 671910 is a sterile, single-use medical device. Best practices focus on proper storage, accurate product selection, sterile preparation, implanted port access, Y-site management, site monitoring, power-injection verification, safety activation, and disposal.

• Store unopened sets according to current manufacturer-recommended environmental conditions.
• Protect packages from moisture, excessive temperatures, crushing, punctures, and contamination.
• Rotate inventory according to expiration dates and facility stock-control procedures.
• Verify the BD 671910 or manufacturer SKU 0671910 before opening the package.
• Confirm the 19-gauge size, 1-inch needle length, and presence of the Y-injection site.
• Assess the patient's tissue depth and implanted port position before selecting the needle length.
• Confirm that the prescribed therapy and required flow characteristics are appropriate for a 19-gauge access device.
• Use strict aseptic technique during preparation, priming, insertion, connection, and dressing application.
• Prime the complete fluid pathway before accessing the implanted vascular port.
• Consider the approximately 0.4 mL priming volume when precise fluid management is clinically important.
• Stabilize the implanted port during both needle insertion and removal.
• Position the tubing to minimize pulling, twisting, or pressure at the access site.
• Disinfect the Y-injection site according to institutional protocol before every access.
• Keep unused access points appropriately protected from contamination.
• Monitor the implanted port site and tubing connections throughout therapy.
• Verify that the entire vascular-access system is appropriately rated before any power-injection procedure.
• Do not exceed 5 mL per second or the lowest pressure or flow-rate limit of any component within the complete system.
• Do not bend, cut, modify, repair, or otherwise alter the infusion set.
• Do not reuse, clean, resterilize, or reprocess the single-use device.
• Confirm complete safety activation immediately following needle withdrawal.
• Place the protected device directly into an approved sharps container.

Regulatory and Safety Information

The BD 671910 PowerLoc Safety Infusion Set should be used only by appropriately trained healthcare professionals and only for applications consistent with current manufacturer labeling, implanted port instructions, professional clinical judgment, and institutional policy.

Before use, verify the product identity, 19-gauge size, 1-inch needle length, Y-injection site configuration, sterile package integrity, expiration date, and compatibility with the implanted vascular port. Do not use a device that is expired, damaged, contaminated, or supplied in compromised packaging.

The set should not be used for power injection unless the implanted port and every component within the complete fluid pathway are specifically rated for the intended procedure. Permitted pressure, flow rate, contrast-media characteristics, and other operating conditions must be confirmed before use.

BD identifies the corresponding 19-gauge PowerLoc configuration with a maximum flow rate of 5 mL per second. The lowest-rated component within the complete vascular-access system determines the actual maximum allowable operating limit.

Incorrect needle-length selection, incomplete septum access, excessive pressure, needle displacement, or improper securement may contribute to infiltration, extravasation, leakage, tissue injury, implanted port damage, interrupted therapy, or other complications.

The Y-injection site should be accessed only with compatible devices using appropriate disinfection and aseptic technique. Improper manipulation or inadequate disinfection may increase the risk of contamination, connection problems, or bloodstream infection.

The integrated safety mechanism should be activated according to current manufacturer instructions. The device remains a contaminated sharp following deaccessing and should be discarded immediately in an approved sharps container.

BD lists manufacturer SKU 0671910 in packages of 20 per shelfpack with a minimum order quantity of one shelfpack. Purchasing personnel should confirm current availability, storage requirements, shipping eligibility, order quantities, and applicable return conditions before purchasing.

How to Order

Select the BD 671910 - PowerLoc Safety Infusion Set with Y-Injection Site, 19G x 1" and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, or further assistance, contact CIA Medical customer service at (312)275-5850 or use the contact form on this page.